-
admin
Posts
Pioneering Nutricosmetics Research Provides Insight into Skin Health Solutions Through Advanced Supplement Technologies
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) — The “Growth Opportunities in Emerging Nutricosmetics Technologies, 2024-2029” report has been added to ResearchAndMarkets.com’s offering. Consumer awareness regarding...
Mens Grooming Products Market to hit USD 89.8 billion by 2032, says Global Market Insights Inc.
Mens grooming products industry is projected to witness a CAGR of 5.6% during the period 2024-2032. This growth can be attributed to expansion of e-commerce...
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir™ consumer...
MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting
CARMEL, Ind., Sept. 30, 2024 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
Wellinks Acquires Spire Health Creating Industry Leader in Predictive Patient Care for Cardiopulmonary Health
Current customers and patients will continue with existing programs while integrated and enhanced solutions are expected in coming months NEW HAVEN, Conn., Sept. 30, 2024...
Ocuphire Pharma Announces Publication of Full Phase 3 Results of Phentolamine Ophthalmic Solution 0.75% for Pharmacologically-Induced Mydriasis in Ophthalmology
Published data from two Phase 3 clinical trials demonstrated rapid reversal of pharmacologically-induced mydriasis with favorable safety profile FARMINGTON HILLS, Mich., Sept. 30, 2024 (GLOBE...
Avalyn Announces Upcoming Presentations on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the 22nd International Colloquium on Lung and Airway Fibrosis
CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of...
GenEditBio Secures Strategic Investment from Gobi Partners GBA to Accelerate Breakthrough Genome Editing Technologies
HONG KONG, Sept. 30, 2024 /PRNewswire/ — GenEditBio Limited (“GenEditBio”), a biotech company co-founded by Prof. ZHENG Zongli from the City University of Hong Kong...
HungryPanda Raises $55 Million led by Mars Growth Capital, to Accelerate Expansion and Service Enhancements
NEW YORK, Sept. 30, 2024 /PRNewswire/ — HungryPanda, the world’s leading overseas Asian food delivery platform, today announced the successful completion of a $55 million...
AV-Comparatives Announces Outstanding Results of Cybersecurity Solutions in 2024 Endpoint Prevention and Response (EPR) Test
Download the full report here. INNSBRUCK, Austria, Sept. 30, 2024 /PRNewswire/ — AV-Comparatives, the globally recognized authority in independent cybersecurity testing, has released its 2024...
